Related Experiment Video
Updated: May 19, 2026
09:19
Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation
Published on: December 8, 2017
Neuroinflammation, neurodegeneration, and depression
Laura L Hurley1, Yousef Tizabi
1Department of Pharmacology, College of Medicine, Howard University, 520 W Street NW, Washington, DC 20059, USA.
Neurotoxicity Research
|August 17, 2012
Summary
Neuroinflammation contributes to neurodegeneration and depression, especially in aging individuals. Research into neuroprotectants like ketamine offers hope for managing these interconnected conditions.
Area of Science:
- Neuroscience
- Immunology
- Gerontology
Background:
- Neurodegeneration and depression frequently co-occur, particularly in aging populations.
- Neuroinflammation is a significant factor linking these conditions, stemming from cytokine dysregulation.
- Aging can lead to immune dysregulation, exacerbating neuroinflammation.
Purpose of the Study:
- To explore the link between neuroinflammation, neurodegeneration, and depression.
- To review the efficacy of various neuroprotectants in mitigating neuroinflammation.
- To highlight the therapeutic potential of neuroprotectants for related conditions.
Main Methods:
- Literature review focusing on neuroinflammation's role.
- Analysis of research on neuroprotectants such as nicotine, alcohol, resveratrol, curcumin, and ketamine.
- Examination of studies connecting cytokine dysregulation to disease pathology.
Main Results:
- Neuroinflammation, driven by cytokine imbalance, is a key mediator in neurodegeneration and depression.
- Several compounds, including ketamine, show promise as neuroprotectants by targeting neuroinflammation.
- Understanding these mechanisms offers potential therapeutic avenues.
Conclusions:
- Targeting neuroinflammation is crucial for treating co-morbid neurodegeneration and depression.
- Neuroprotectants represent a promising strategy for managing age-related neurological and mood disorders.
- Further research is needed to optimize neuroprotectant therapies for neuroinflammation-driven conditions.
More Related Videos
Related Concept Videos
01:18Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
01:28Disorders of the Nervous Tissue
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:03Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Calcium Ion Concentration Mechanism
If over time, all...
01:05Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.